To award Indefinite Delivery Indefinite Quantity (IDIQ) Contract for a Biologic
Closed Pre-Solicitation Posted
Not the latest version. See the latest special notice from .
- Solicitation number
- 75N94024R00034
- Agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
Summary of Key Details:
The Department of Health and Human Services, National Institutes of Health, National Institute of Child Health and Human Development (NICHD) is seeking to award an Indefinite Delivery Indefinite Quantity (IDIQ) contract for a Biological Testing Facility (BTF) to support the preclinical development of contraceptive products. The BTF will be responsible for conducting discovery, optimization, biological safety, and efficacy evaluations of compounds as anti-fertility agents to satisfy regulatory requirements for clinical trials. The NAICS code is 541715 with a size standard of 1,000 employees or less. The period of performance is anticipated to be September 3, 2025 to September 2, 2032. Interested parties should submit written capability statements addressing their experience, personnel, and facilities relevant to providing these preclinical services by August 26, 2024. The Request for Proposal is anticipated to be posted on or around January 10, 2025.
This opportunity is not set-aside for any specific business type. The sources sought synopsis does not identify any potential incumbents or current contractors. The budget range or award values are not provided. However, the scope of work suggests a significant contracting opportunity to support the preclinical development of contraceptive products for the NICHD.
Notice text
The Biological Testing Facility (BTF) fulfills a unique role in bridging the discovery of contraceptive targets to the development and approval of the contraceptive products. To this end, the studies at the BTF will encompass discovery and optimization of compounds as anti-fertility agents. In addition, the BTF has an important role in enriching and providing the pre-clinical support services necessary to make progress toward the development of high quality, safe and effective male and female contraceptive products.
Files
| File | Type | Posted |
|---|---|---|
| SOURCES_SOUGHT_SYNOPSIS_Final_BTF25_1.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| To award Indefinite Delivery Indefinite Quantity (IDIQ) Contract for a Biologic | Special Notice | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity